Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 23.39
-2.74 %
$ 1.08 B
Market Cap
-10.88
P/E
PCRX - REVENUE
Revenue PCRX - Pacira BioSciences, Inc.
675 M
LAST VALUE
11.64%
2 YEAR CAGR
14.88%
5 YEAR CAGR
22.94%
10 YEAR CAGR